USANA Health Sciences, Inc. (NYSE:USNA) Shares Bought by Pzena Investment Management LLC

Pzena Investment Management LLC raised its holdings in USANA Health Sciences, Inc. (NYSE:USNA) by 3.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 1,087,076 shares of the company’s stock after acquiring an additional 37,466 shares during the period. Pzena Investment Management LLC owned 0.06% of USANA Health Sciences worth $39,015,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Martingale Asset Management L P increased its holdings in shares of USANA Health Sciences by 2.1% during the 3rd quarter. Martingale Asset Management L P now owns 16,732 shares of the company’s stock worth $634,000 after buying an additional 340 shares during the last quarter. KBC Group NV increased its holdings in shares of USANA Health Sciences by 96.6% during the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock worth $40,000 after buying an additional 519 shares during the last quarter. R Squared Ltd acquired a new stake in shares of USANA Health Sciences during the 4th quarter worth $28,000. Safe Harbor Fiduciary LLC acquired a new stake in shares of USANA Health Sciences during the 3rd quarter worth $30,000. Finally, Exchange Traded Concepts LLC increased its holdings in shares of USANA Health Sciences by 11.3% during the 4th quarter. Exchange Traded Concepts LLC now owns 8,578 shares of the company’s stock worth $308,000 after buying an additional 869 shares during the last quarter. 54.25% of the stock is currently owned by institutional investors and hedge funds.

USANA Health Sciences Trading Up 0.7 %

Shares of USANA Health Sciences stock opened at $33.18 on Tuesday. The company has a fifty day moving average price of $32.96 and a 200 day moving average price of $36.18. USANA Health Sciences, Inc. has a twelve month low of $27.71 and a twelve month high of $50.32. The stock has a market cap of $632.47 million, a price-to-earnings ratio of 11.73, a price-to-earnings-growth ratio of 0.93 and a beta of 0.98.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.15. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The firm had revenue of $213.61 million during the quarter, compared to analysts’ expectations of $208.82 million. Analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on USNA. DA Davidson dropped their price objective on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating for the company in a report on Thursday, February 27th. Sidoti downgraded USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 18th. Finally, StockNews.com downgraded USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th.

Insider Buying and Selling

In other USANA Health Sciences news, CEO Jim Brown sold 5,000 shares of the company’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $29.47, for a total value of $147,350.00. Following the completion of the transaction, the chief executive officer now directly owns 15,716 shares of the company’s stock, valued at $463,150.52. This represents a 24.14 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In the last three months, insiders sold 6,454 shares of company stock valued at $190,459. Company insiders own 0.33% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.